Table 3.
lncRNAs showing strongest evidence for differential expression in LX-2 cells exposed to conditioned media from palmitate-treated hepatocytes.
| ID | Gene Symbol | Associated Gene | Normalized intensity | |||
|---|---|---|---|---|---|---|
| FDR | Log2FC | 1 mM* | 0 mM* | |||
| T173832 | G040382 | 7.3E-06 | 6.67 | 14.37 | 7.64 | |
| NR_105039 | LOC101927488 | 7.3E-06 | 6.61 | 14.06 | 7.36 | |
| T314169 | G073685 | 7.3E-06 | 6.46 | 14.85 | 8.36 | |
| ENST00000580967 | RP11-527H14.2 | 7.3E-06 | 6.46 | 14.83 | 8.33 | |
| ENST00000597156 | CTD-3193013.11 | Proline rich 36 (PRR36) | 7.3E-06 | 6.30 | 14.03 | 7.65 |
| NR_125419 | LOC101927543 | Syntrophin beta 1 (SNTB1) | 7.3E-06 | 6.24 | 14.92 | 8.65 |
| TCONS_00018312 | XLOC_008586 | 7.3E-06 | 6.22 | 15.38 | 9.15 | |
| TCONS_00014675 | XLOC_006774 | 7.3E-06 | 6.16 | 16.09 | 9.93 | |
| ENST00000416861 | AC009502.4 | 7.3E-06 | 6.07 | 15.56 | 9.49 | |
| TCONS_12_00017992 | XLOC_12_009508 | 7.3E-06 | 6.05 | 14.70 | 8.63 | |
| T119684 | G028271 | Secretory carrier membrane protein 5 (SCAMP5) | 7.3E-06 | 5.90 | 14.26 | 8.34 |
| ENST00000566418 | RP11-686F15.2 | 7.3E-06 | 5.87 | 14.11 | 8.17 | |
| T271295 | G062886 | 7.3E-06 | 5.87 | 12.63 | 6.64 | |
| ENST00000423020 | RP5-963E22.4 | 7.3E-06 | 5.87 | 14.40 | 8.49 | |
| TCONS_00014959 | XLOC_007038 | 7.3E-06 | 5.80 | 13.81 | 7.91 | |
| T372494 | G087836 | 7.3E-06 | 5.78 | 13.94 | 8.10 | |
| TCONS_00000947 | XLOC_000202 | 7.3E-06 | 5.75 | 14.51 | 8.72 | |
| NR_002165 | HMGB3P1 | 7.3E-06 | 5.75 | 13.14 | 7.28 | |
| T085588 | G019854 | 7.3E-06 | 5.74 | 12.14 | 6.16 | |
| ENST00000531886 | RP11-110I1.6 | Hypoxia upregulated 1 (HYOU1) | 7.3E-06 | 5.68 | 13.52 | 7.78 |
*
concentration of palmitate used to treat PHH